Disease-related and psychosocial factors associated with depressive symptoms in patients with systemic sclerosis, including fear of progression and appearance self-esteem

Journal of Psychosomatic Research

Volumn 72, Issue 3, 2012, Pages 199-204

  Kwakkenbos, Linda ^a   van Lankveld, Wim G J M ^a   Vonk, Madelon C ^b   Becker, Eni S ^c   van den Hoogen, Frank H J ^a   van den Ende, Cornelia H M ^a  

^a Sint Maartenskliniek Nijmegen ^*  (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Appearance self esteem; Depression; Fatigue; Fear of progression; Pain; Systemic sclerosis

Indexed keywords

ADULT; ARTICLE; CENTER FOR EPIDEMIOLOGIC STUDY DEPRESSION SCALE; COPING BEHAVIOR; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; FATIGUE; FEAR; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HELPLESSNESS; HUMAN; ILLNESS COGNITION QUESTIONNAIRE; MAJOR CLINICAL STUDY; MALE; PAIN; PAIN ASSESSMENT; PATIENT SATISFACTION; QUESTIONNAIRE; RATING SCALE; RODNAN SKIN SCORE; SCLERODERMA HEALTH ASSESSMENT QUESTIONNAIRE; SCORING SYSTEM; SELF ESTEEM; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; SYSTEMIC SCLEROSIS; VISUAL ANALOG SCALE;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; DEMOGRAPHY; DEPRESSION; DISEASE PROGRESSION; FATIGUE; FEAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PREVALENCE; PSYCHOLOGY; PSYCHOPHYSIOLOGY; QUESTIONNAIRES; SCLERODERMA, SYSTEMIC; SELF CONCEPT; SEVERITY OF ILLNESS INDEX; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS;

EID: 84856640227     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2011.12.005     Document Type: Article

References (42)

1. Thombs BD, van Lankveld W, Bassel M, Baron M, Buzza R, Haslam S, et al. Psychological health and well-being in systemic sclerosis: state of the science and consensus research agenda. Arthritis Care Res 2010, 62:1181-1189.
2. Vonk MC, Broers B, Heijdra YF, Ton E, Snijder R, van Dijk AP, et al. Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study. Ann Rheum Dis 2009, 68:961-965.
3. Gabrielli A, Avvedimento EV, Krieg T Scleroderma: mechanisms of the disease. N Engl J Med 2009, 360:1989-2003.
4. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA, Lucas M, Michet CJ, et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005, 118:2-10.
5. Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M Canadian Scleroderma Research Group. Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheum 2009, 61:1112-1120.
6. Suarez-Almazor ME, Kallen MA, Roundtree AK, Mayes M Disease and symptom burden in systemic sclerosis. J Rheumatol 2007, 34:1718-1726.
7. Joachim G, Acorn S Life with a rare chronic disease: the scleroderma experience. J Adv Nurs 2003, 42:598-606.
8. Schnitzer M, Hudson M, Baron M, Steele R, Canadian Scleroderma Research Group Disability in systemic sclerosis - a longitudinal observational study. J Rheumatol 2011, 38:685-692.
9. Thombs BD, Taillefer SS, Hudson M, Baron M Depression in patients with systemic sclerosis: a systematic review of the evidence. Arthritis Rheum 2007, 57:1089-1097.
10. Schouffoer AA, Zirkzee EJ, Henquet SM, Caljouw MA, Steup-Beekman GM, van Laar JM, et al. Needs and preferences regarding health care delivery as perceived by patients with systemic sclerosis. Clin Rheumatol 2011, 30:815-824.
11. Teunissen HA, van Lankveld WGJM, Vonk MC, van den Hoogen FHJ Systemische Sclerose: de gevolgen voor het psychisch en lichamelijk functioneren, en de behoefte aan begeleiding. Ned Tijdschr Reumatol 2005, 4:8-12.
12. Herschbach P, Berg P, Dankert A, Duran G, Engst-Hastreiter U, Waadt S, et al. Fear of progression in chronic diseases: psychometric properties of the Fear of Progression Questionnaire. J Psychosom Res 2005, 58:505-511.
13. Mehnert A, Herschbach P, Berg P, Henrich G, Koch U Progredienzangst bei Brustkrebspatientinnen- Validierung der Kurzform de Progredienzangstfragebogens PA-F-KF. Z Psychosom Med Psychother 2006, 52:274-288.
14. Paguette DL, Falanga V Cutaneous concerns of scleroderma patients. J Dermatol 2003, 30:438-443.
15. Benrud-Larson LM, Heinberg LJ, Boling C, Reed J, White B, Wigley FM, et al. Body image dissatisfaction among women with scleroderma: extend and relationship to psychosocial function. Health Psychol 2003, 22:130-139.
16. Malcarne VL, Hansdottir I, Greenbergs HL, Clements PJ, Weisman MH Appearance self-esteem in systemic sclerosis. Cogn Ther Res 1999, 23:197-208.
17. Van Lankveld WGJM, Vonk MC, Teunissen HA, van den Hoogen FHJ Appearance self-esteem in systemic sclerosis- subjective experience of skin deformity and its relationship with physician-assessed skin involvement, disease status and psychological variables. Rheumatology 2007, 46:972-976.
18. Roca RP, Wigley FM, White B Depressive symptoms associated with scleroderma. Arthritis Rheum 1996, 39:1035-1040.
19. Nietert PJ, Mitchell HC, Bolster MB, Curran MY, Tilley BC, Silver RM Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. J Rheumatol 2005, 32:51-57.
20. Thombs BD, Hudson M, Taillefer SS, Baron M Canadian Scleroderma Research Group. Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis. Arthritis Rheum 2008, 59:504-509.
21. Van Lankveld WGJM, Teunissen HA, Näring G, Vonk MC, van den Hoogen FHJ Social support, disease-related cognitions and coping as predictors of depressed mood in systemic sclerosis. Cogn Ther Res 2008, 32:434-447.
22. Hyphantis TN, Tsifetaki N, Pappa C, Voulgari RV Clinical features and personality traits associated with psychological distress in systemic sclerosis patients. J Psychosom Res 2007, 62:47-56.
23. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostics and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980, 23:581-590.
24. Fries JF, Spitz P, Kraines RG, Holman HR Measurement of patient outcomes in arthritis. Arthritis Rheum 1980, 23:137-145.
25. Steen VD, Medsger TA The value of the health assessment questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997, 40:1984-1991.
26. Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 1994, 38:383-392.
27. Radloff LS The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977, 1:385-401.
28. Thombs BD, Hudson M, Schieir O, Taillefer SS, Baron M Canadian Scleroderma Research Group. Reliability and validity of the Center for Epidemiologic Studies Depression Scale in patients with systemic sclerosis. Arthritis Rheum 2008, 59:438-443.
29. Martens MP, Parker JC, Smarr KL, Hewett JE, Slaughter JR, Walker SE Assessment of depression in rheumatoid arthritis: a modified version of the Center for Epidemiologic Studies Depression Scale. Arthritis Rheum 2003, 49:549-555.
30. Brandt P, Weinert C The PRQ - a social support measure. Nurs Res 1981, 30:277-280.
31. Weinert C Evaluation of the Personal Resource Questionnaire: a social support measure. Birth Defects 1984, 20:59-97.
32. Moser DK, Clements PJ, Brecht ML, Weiner SR Predictors of psychosocial adjustment in systemic sclerosis: the influence of formal educational level, functional ability, hardiness, uncertainty, and social support. Arthritis Rheum 1993, 36:1398-1405.
33. Endler NS, Parker JDA, De Ridder DTD, Van Heck GL Coping Inventory for Stressful Situations: CISS Handleiding 2004, Swets Test Publishers.
34. McWilliams LA, Cox BJ, Enns MW Use of the Coping Inventory for Stressful Situations in a clinically depressed sample: factor structure, personality correlates, and prediction of distress. J Clin Psychol 2003, 59:423-437.
35. Evers AW, Kraaimaat FW, van LW, Jongen PJ, Jacobs JW, Bijlsma JW Beyond unfavorable thinking: the illness cognition questionnaire for chronic diseases. J Consult Clin Psychol 2001, 69:1026-1036.
36. Heatherton TF, Polivy J Development and validation of a scale for measuring state self-esteem. J Pers Soc Psychol 1991, 60:895-910.
37. Hale ED, Treharne GJ, Kitas GD The common-sense model of self-regulation of health and illness: how can we use it to understand and respond to our patients' needs. Rheumatology 2007, 46:904-906.
38. Hagger MS, Orbell S A meta-analytic review of the common-sense model of illness representations. Psychol Health 2003, 18:141-184.
39. Steyerberg EW Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating 2009, Springer, New York.
40. Morris A, Yelin EH, Panopalis P, Julian L, Katz PP Long-term patterns of depression and associations with health and function in a panel study of rheumatoid arthritis. J Health Psychol 2011, 16:667-677.
41. Herschbach P, Book K, Dinkel A, Berg P, Waadt S, Duran G, et al. Evaluation of two group therapies to reduce fear of progression in cancer patients. Support Care Cancer 2010, 18:471-479.
42. Thombs BD, Fuss S, Hudson M, Schieir O, Taillefer SS, Fogel J, et al. High rates of depressive symptoms among patients with systemic sclerosis are not explained by differential reporting of somatic symptoms. Arthritis Rheum 2008, 59:431-437.